CRISPR THERAPEUTICS LTD

The current price of 1CG is 40.00 EUR — it hasn't changed in the past 24 hours. Watch CRISPR THERAPEUTICS LTD stock price performance more closely on the chart.

Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange CRISPR THERAPEUTICS LTD stocks are traded under the ticker 1CG.

CRISPR THERAPEUTICS LTD is going to release the next earnings report on Jul 29, 2024. Keep track of upcoming events with our Earnings Calendar.

1CG stock is 0% volatile and has beta coefficient of 2.60. Track CRISPR THERAPEUTICS LTD stock price on the chart and check out the list of the most volatile stocks — is CRISPR THERAPEUTICS LTD there?

1CG earnings for the last quarter are −1.33 EUR per share, whereas the estimation was −1.26 EUR resulting in a −5.08% surprise. The estimated earnings for the next quarter are −1.41 EUR per share. See more details about CRISPR THERAPEUTICS LTD earnings.

CRISPR THERAPEUTICS LTD revenue for the last quarter amounts to ‪467.10 K‬ EUR despite the estimated figure of ‪21.36 M‬ EUR. In the next quarter revenue is expected to reach ‪5.47 M‬ EUR.

Yes, you can track CRISPR THERAPEUTICS LTD financials in yearly and quarterly reports right on TradingView.

Today CRISPR THERAPEUTICS LTD has the market capitalization of ‪4.03 B‬, it has decreased by 4.28% over the last week.

No, 1CG doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, 1CG shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CRISPR THERAPEUTICS LTD stock right from TradingView charts — choose your broker and connect to your account.

1CG reached its all-time high on May 24, 2018 with the price of 63.50 EUR, and its all-time low was 11.94 EUR and was reached on Jun 1, 2017. View more price dynamics on 1CG chart.
See other stocks reaching their highest and lowest prices.

As of May 11, 2024, the company has 407.00 employees. See our rating of the largest employees — is CRISPR THERAPEUTICS LTD on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CRISPR THERAPEUTICS LTD technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CRISPR THERAPEUTICS LTD stock shows the buy signal. See more of CRISPR THERAPEUTICS LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

We've gathered analysts' opinions on CRISPR THERAPEUTICS LTD future price: according to them, 1CG price has a max estimate of 184.57 EUR and a min estimate of 27.82 EUR. Watch 1CG chart and read a more detailed CRISPR THERAPEUTICS LTD stock forecast: see what analysts think of CRISPR THERAPEUTICS LTD and suggest that you do with its stocks.